shutterstock_520591576
News
Lyndra forms strategic clinical research and commercial manufacturing services collaboration with Thermo Fisher for...
Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, has entered a strategic collaboration with Thermo Fisher Scientific, in which Thermo Fisher will...
Formycon and Fresenius Kabi secure MHRA approval for Stelara biosimilar
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for Fresenius Kabi and Formycon's ustekinumab biosimilar candidate, indicated for the...
REGENXBIO and Nippon Shinyaku partner to develop and commercialize Hunter and Hurler syndrome treatments
REGENXBIO and Nippon Shinyaku have formed a strategic partnership for the development and commercialization of RGX-121 for the treatment of Mucopolysaccharidosis II (MPS II),...
